Breadth of T Cell Responses After Immunization with Adenovirus Vectors Encoding Ancestral Antigens or Polyvalent Papillomavirus Antigens (Q40370393)

19 September 2017

Breadth of T Cell Responses After Immunization with Adenovirus Vectors Encoding Ancestral Antigens or Polyvalent Papillomavirus Antigens (English)

1 reference

19 September 2017

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28109028%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Anders Gorm Pedersen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28109028%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Peter Johannes Holst

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28109028%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

author name string

E Ragonnaud

1

1 reference

19 September 2017

A G Pedersen

2

1 reference

19 September 2017

P J Holst

3

1 reference

19 September 2017

language of work or name

1 reference

21 January 2017

1 reference

Scandinavian Journal of Immunology

19 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28109028%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

volume

85

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28109028%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28109028%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

page(s)

182-190

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28109028%20AND%20SRC:MED&resulttype=core&format=json

Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial.

10 June 2020

cites work

1 reference

HPV vaccine completion and dose adherence among commercially insured females aged 9 through 26 years in the US.

21 January 2018

1 reference

Molecular biology of human papillomavirus infection and cervical cancer

21 January 2018

1 reference

HPV16 E2 is an immediate early marker of viral infection, preceding E7 expression in precursor structures of cervical carcinoma

21 January 2018

1 reference

Effectiveness of HPV 16 viral load and the E2/E6 ratio for the prediction of cervical cancer risk among Chinese women.

21 January 2018

1 reference

Immunological events in regressing genital warts

21 January 2018

1 reference

Human papillomavirus 16-specific cell-mediated immunity in children born to mothers with incident cervical intraepithelial neoplasia (CIN) and to those constantly HPV negative

21 January 2018

1 reference

Genomic diversity and interspecies host infection of alpha12 Macaca fascicularis papillomaviruses (MfPVs).

21 January 2018

1 reference

Characterization and experimental transmission of an oncogenic papillomavirus in female macaques.

21 January 2018

1 reference

MHC Class II-Associated Invariant Chain Linkage of Antigen Dramatically Improves Cell-Mediated Immunity Induced by Adenovirus Vaccines

21 January 2018

1 reference

Fusion of HCV nonstructural antigen to MHC class II-associated invariant chain enhances T-cell responses induced by vectored vaccines in nonhuman primates

21 January 2018

1 reference

4-1BBL enhances CD8+ T cell responses induced by vectored vaccines in mice but fails to improve immunogenicity in rhesus macaques

21 January 2018

1 reference

Enhanced vaccine-induced CD8+ T cell responses to malaria antigen ME-TRAP by fusion to MHC class ii invariant chain

21 January 2018

1 reference

Enhanced and sustained CD8+ T cell responses with an adenoviral vector-based hepatitis C virus vaccine encoding NS3 linked to the MHC class II chaperone protein invariant chain

21 January 2018

1 reference

MAFFT Multiple Sequence Alignment Software Version 7: Improvements in Performance and Usability

21 January 2018

1 reference

ProtTest 3: fast selection of best-fit models of protein evolution

21 January 2018

1 reference

MrBayes 3: Bayesian phylogenetic inference under mixed models

21 January 2018

1 reference

Genetic manipulation of poxviruses using bacterial artificial chromosome recombineering

21 January 2018

1 reference

HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity

21 January 2018

1 reference

Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4+T-cell-independent CD8+T-cell-mediated tumor control

21 January 2018

1 reference

Quality of the transgene-specific CD8+ T cell response induced by adenoviral vector immunization is critically influenced by virus dose and route of vaccination

21 January 2018

1 reference

Adenoviral vaccination combined with CD40 stimulation and CTLA-4 blockage can lead to complete tumor regression in a murine melanoma model

21 January 2018

1 reference

An adenoviral cancer vaccine co-encoding a tumor associated antigen together with secreted 4-1BBL leads to delayed tumor progression.

21 January 2018

1 reference

The role of CD80/CD86 in generation and maintenance of functional virus-specific CD8+ T cells in mice infected with lymphocytic choriomeningitis virus

21 January 2018

1 reference

Qualitative and quantitative analysis of adenovirus type 5 vector-induced memory CD8 T cells: not as bad as their reputation.

21 January 2018

1 reference

Vaccine vectors derived from a large collection of simian adenoviruses induce potent cellular immunity across multiple species

21 January 2018

1 reference

Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation

21 January 2018

1 reference

The impact of HAART on HPV-related cervical disease

21 January 2018

1 reference

The influence of human papillomavirus type and HIV status on the lymphomononuclear cell profile in patients with cervical intraepithelial lesions of different severity

21 January 2018

1 reference

Balance between transmitted HLA preadapted and nonassociated polymorphisms is a major determinant of HIV-1 disease progression.

21 January 2018

1 reference

Combined single-clade candidate HIV-1 vaccines induce T cell responses limited by multiple forms of in vivo immune interference

21 January 2018

1 reference

Pre-existing vector immunity does not prevent replication deficient adenovirus from inducing efficient CD8 T-cell memory and recall responses

21 January 2018

1 reference

Therapeutic human papillomavirus vaccines: current clinical trials and future directions

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/SJI.12522

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28109028%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

1 reference